Circadian REV-ERBs repress E4bp4 to activate NAMPT-dependent NAD+ biosynthesis and sustain cardiac function
2021 · Nature Cardiovascular Research · 64 citations
https://doi.org/10.1038/s44161-021-00001-9
T
Tsunehisa Yamamoto
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
2.3K
Citations
21
h-index
27
i10-index
Tsunehisa Yamamoto is an academic researcher from Bristol-Myers Squibb (Japan). The author has contributed to research in topics: Adipose Tissue and Metabolism & Pulmonary Hypertension Research and Treatments & Mitochondrial Function and Pathology. The author has an h-index of 21, co-authored 71 publications.
ORCID: 0000-0002-5241-9482Papers by this author
worksLabel-free Evaluation of Myocardial Infarct in Surgically Excised Ventricular Myocardium by Raman Spectroscopy
2018 · Scientific Reports · 46 citations
https://doi.org/10.1038/s41598-018-33025-6
Endothelial–Mesenchymal Transition Drives Expression of CD44 Variant and xCT in Pulmonary Hypertension
2019 · American Journal of Respiratory Cell and Molecular Biology · 35 citations
https://doi.org/10.1165/rcmb.2018-0231oc
The complement C3-complement factor D-C3a receptor signalling axis regulates cardiac remodelling in right ventricular failure
2022 · Nature Communications · 30 citations
https://doi.org/10.1038/s41467-022-33152-9
Pulmonary Thromboembolism Developed During Hospitalization: A Nationwide Retrospective Observational Study Using Claims Data
2022 · Cardiology and Therapy · 7 citations
https://doi.org/10.1007/s40119-022-00290-6
Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study
2015 · BMC Pulmonary Medicine · 5 citations
https://doi.org/10.1186/s12890-015-0037-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat